Dow Jones

38,798.99

-0.22%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

IDMI

Idm Pharma (IDMI)

Idm Pharma (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDMI

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
24/06/2009	15:42	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:IDMI	Idm Pharma (MM)
24/06/2009	15:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IDMI	Idm Pharma (MM)
24/06/2009	15:38	Edgar (US Regulatory)	(25-NSE)	NASDAQ:IDMI	Idm Pharma (MM)
23/06/2009	11:42	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:IDMI	Idm Pharma (MM)
23/06/2009	08:40	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:IDMI	Idm Pharma (MM)
01/06/2009	22:14	Dow Jones News	CORRECT: Takeda's Millennium Looking For Deals To Bolster Pipeline	NASDAQ:IDMI	IDM Pharma Inc.
01/06/2009	14:59	Dow Jones News	Takeda's Millennium Looking For Deals To Bolster Pipeline	NASDAQ:IDMI	IDM Pharma Inc.
28/05/2009	13:07	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:IDMI	Idm Pharma (MM)
26/05/2009	11:29	Edgar (US Regulatory)	Statement of Ownership: Solicitation (SC 14D9)	NASDAQ:IDMI	Idm Pharma (MM)
26/05/2009	11:17	Edgar (US Regulatory)	Tender offer statement by Third Party (SC TO-T)	NASDAQ:IDMI	Idm Pharma (MM)
19/05/2009	08:20	PR Newswire (US)	Stock Alerts on Tuesday's Small and Large-Cap Movers; Issued by Beacon Equity	NASDAQ:IDMI	Idm Pharma (MM)
18/05/2009	16:16	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:IDMI	Idm Pharma (MM)
18/05/2009	11:28	Edgar (US Regulatory)	Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:IDMI	Idm Pharma (MM)
18/05/2009	11:05	Edgar (US Regulatory)	Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:IDMI	Idm Pharma (MM)
18/05/2009	03:00	PR Newswire (US)	Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Year	NASDAQ:IDMI	Idm Pharma (MM)
13/05/2009	15:42	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/A)	NASDAQ:IDMI	Idm Pharma (MM)
11/05/2009	11:18	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:IDMI	Idm Pharma (MM)
11/05/2009	06:30	PR Newswire (US)	IDM Pharma Reports First Quarter Financial Results	NASDAQ:IDMI
30/04/2009	12:57	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:IDMI	Idm Pharma (MM)
13/04/2009	06:30	PR Newswire (US)	IDM Pharma Receives Nasdaq Shareholder Equity Notification	NASDAQ:IDMI	Idm Pharma (MM)
03/04/2009	06:30	PR Newswire (US)	IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fisca	NASDAQ:IDMI	Idm Pharma (MM)
31/03/2009	15:30	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:IDMI	Idm Pharma (MM)
31/03/2009	06:30	PR Newswire (US)	IDM Pharma Reports 2008 Financial Results	NASDAQ:IDMI	Idm Pharma (MM)
09/03/2009	10:26	PR Newswire (US)	IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resect	NASDAQ:IDMI	Idm Pharma (MM)
26/02/2009	07:00	PR Newswire (US)	IDM Pharma Joins NORD to Raise Awareness of Rare Diseases	NASDAQ:IDMI	Idm Pharma (MM)
06/02/2009	13:15	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:IDMI	Idm Pharma (MM)
04/02/2009	11:54	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:IDMI	Idm Pharma (MM)
18/12/2008	12:32	PR Newswire (US)	IDM Pharma Provides Update on Mifamurtide (MEPACT(R), L-MTP-PE) European Regulatory Status	NASDAQ:IDMI	Idm Pharma (MM)
18/11/2008	06:30	PR Newswire (US)	IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Meta	NASDAQ:IDMI	Idm Pharma (MM)
13/11/2008	06:30	PR Newswire (US)	IDM Pharma Reports Third Quarter Financial Results	NASDAQ:IDMI	Idm Pharma (MM)